Posted Jun. 2, 2014 at 7:12 a.m.

Premium Lock Reports: GSK in $350M deal to develop cancer drugs

Published: 2014-06-02 07:12:06
Updated: 2014-06-02 07:12:06


GlaxoSmithKline has agreed to a deal worth more than $350 million with UK biotech company Adaptimmune to develop cancer drugs, the Financial Times reported on Monday....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll